nodes	percent_of_prediction	percent_of_DWPC	metapath
Bendroflumethiazide—TPMT—prostate gland—prostate cancer	0.0117	0.0716	CbGeAlD
Bendroflumethiazide—KCNMA1—prostate gland—prostate cancer	0.0109	0.0666	CbGeAlD
Bendroflumethiazide—SLC12A3—renal system—prostate cancer	0.0107	0.0657	CbGeAlD
Bendroflumethiazide—TPMT—seminal vesicle—prostate cancer	0.00989	0.0606	CbGeAlD
Bendroflumethiazide—KCNMA1—epithelium—prostate cancer	0.00799	0.049	CbGeAlD
Bendroflumethiazide—TPMT—renal system—prostate cancer	0.00797	0.0488	CbGeAlD
Bendroflumethiazide—TPMT—urethra—prostate cancer	0.00783	0.0479	CbGeAlD
Bendroflumethiazide—KCNMA1—renal system—prostate cancer	0.00742	0.0454	CbGeAlD
Bendroflumethiazide—CA4—prostate gland—prostate cancer	0.00646	0.0396	CbGeAlD
Bendroflumethiazide—TPMT—bone marrow—prostate cancer	0.00603	0.0369	CbGeAlD
Bendroflumethiazide—CA1—renal system—prostate cancer	0.00563	0.0345	CbGeAlD
Bendroflumethiazide—CA4—seminal vesicle—prostate cancer	0.00546	0.0335	CbGeAlD
Bendroflumethiazide—CA2—prostate gland—prostate cancer	0.00536	0.0328	CbGeAlD
Bendroflumethiazide—TPMT—testis—prostate cancer	0.00515	0.0315	CbGeAlD
Bendroflumethiazide—KCNMA1—testis—prostate cancer	0.00479	0.0294	CbGeAlD
Bendroflumethiazide—CA2—seminal vesicle—prostate cancer	0.00453	0.0277	CbGeAlD
Bendroflumethiazide—CA4—renal system—prostate cancer	0.0044	0.027	CbGeAlD
Bendroflumethiazide—CA4—urethra—prostate cancer	0.00432	0.0265	CbGeAlD
Bendroflumethiazide—CA1—bone marrow—prostate cancer	0.00426	0.0261	CbGeAlD
Bendroflumethiazide—CA2—epithelium—prostate cancer	0.00394	0.0241	CbGeAlD
Bendroflumethiazide—TPMT—lymph node—prostate cancer	0.00373	0.0229	CbGeAlD
Bendroflumethiazide—CA2—renal system—prostate cancer	0.00365	0.0224	CbGeAlD
Bendroflumethiazide—KCNMA1—lymph node—prostate cancer	0.00347	0.0213	CbGeAlD
Bendroflumethiazide—CA4—bone marrow—prostate cancer	0.00333	0.0204	CbGeAlD
Bendroflumethiazide—CA4—testis—prostate cancer	0.00285	0.0174	CbGeAlD
Bendroflumethiazide—CA2—bone marrow—prostate cancer	0.00276	0.0169	CbGeAlD
Bendroflumethiazide—CA1—lymph node—prostate cancer	0.00264	0.0162	CbGeAlD
Bendroflumethiazide—Muscle spasms—Cabazitaxel—prostate cancer	0.00246	0.00531	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Estramustine—prostate cancer	0.00243	0.00525	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Flutamide—prostate cancer	0.00242	0.00522	CcSEcCtD
Bendroflumethiazide—Anorexia—Nilutamide—prostate cancer	0.00236	0.00511	CcSEcCtD
Bendroflumethiazide—CA2—testis—prostate cancer	0.00236	0.0145	CbGeAlD
Bendroflumethiazide—Anorexia—Flutamide—prostate cancer	0.00235	0.00508	CcSEcCtD
Bendroflumethiazide—Constipation—Abiraterone—prostate cancer	0.00232	0.00501	CcSEcCtD
Bendroflumethiazide—Polyuria—Estradiol—prostate cancer	0.00229	0.00494	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Conjugated Estrogens—prostate cancer	0.00228	0.00493	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Conjugated Estrogens—prostate cancer	0.00226	0.00488	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Estradiol—prostate cancer	0.00224	0.00485	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Nilutamide—prostate cancer	0.00215	0.00466	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Flutamide—prostate cancer	0.00215	0.00464	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Conjugated Estrogens—prostate cancer	0.00213	0.00459	CcSEcCtD
Bendroflumethiazide—Constipation—Nilutamide—prostate cancer	0.00212	0.00458	CcSEcCtD
Bendroflumethiazide—Constipation—Flutamide—prostate cancer	0.00211	0.00456	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Bicalutamide—prostate cancer	0.00211	0.00456	CcSEcCtD
Bendroflumethiazide—Purpura—Estradiol—prostate cancer	0.00208	0.0045	CcSEcCtD
Bendroflumethiazide—Hypotension—Degarelix—prostate cancer	0.00207	0.00447	CcSEcCtD
Bendroflumethiazide—CA4—lymph node—prostate cancer	0.00206	0.0126	CbGeAlD
Bendroflumethiazide—Thrombocytopenia—Cabazitaxel—prostate cancer	0.00204	0.00441	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Goserelin—prostate cancer	0.00202	0.00436	CcSEcCtD
Bendroflumethiazide—Anorexia—Cabazitaxel—prostate cancer	0.00199	0.0043	CcSEcCtD
Bendroflumethiazide—Hypotension—Cabazitaxel—prostate cancer	0.00195	0.00421	CcSEcCtD
Bendroflumethiazide—Asthenia—Abiraterone—prostate cancer	0.00195	0.00421	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Degarelix—prostate cancer	0.00192	0.00416	CcSEcCtD
Bendroflumethiazide—Drug interaction—Docetaxel—prostate cancer	0.00192	0.00415	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Estramustine—prostate cancer	0.00191	0.00413	CcSEcCtD
Bendroflumethiazide—Constipation—Degarelix—prostate cancer	0.00189	0.00409	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Abiraterone—prostate cancer	0.00186	0.00401	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Cabazitaxel—prostate cancer	0.00181	0.00392	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Estradiol—prostate cancer	0.00181	0.00391	CcSEcCtD
Bendroflumethiazide—Constipation—Cabazitaxel—prostate cancer	0.00178	0.00385	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Ethinyl Estradiol—prostate cancer	0.00178	0.00385	CcSEcCtD
Bendroflumethiazide—Asthenia—Nilutamide—prostate cancer	0.00178	0.00384	CcSEcCtD
Bendroflumethiazide—Vomiting—Estramustine—prostate cancer	0.00178	0.00384	CcSEcCtD
Bendroflumethiazide—Asthenia—Flutamide—prostate cancer	0.00177	0.00383	CcSEcCtD
Bendroflumethiazide—Dizziness—Estrone—prostate cancer	0.00176	0.00381	CcSEcCtD
Bendroflumethiazide—Rash—Estramustine—prostate cancer	0.00176	0.00381	CcSEcCtD
Bendroflumethiazide—Dermatitis—Estramustine—prostate cancer	0.00176	0.0038	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Bicalutamide—prostate cancer	0.00175	0.00379	CcSEcCtD
Bendroflumethiazide—Vomiting—Abiraterone—prostate cancer	0.00173	0.00373	CcSEcCtD
Bendroflumethiazide—Rash—Abiraterone—prostate cancer	0.00171	0.0037	CcSEcCtD
Bendroflumethiazide—CA2—lymph node—prostate cancer	0.00171	0.0105	CbGeAlD
Bendroflumethiazide—Dermatitis—Abiraterone—prostate cancer	0.00171	0.00369	CcSEcCtD
Bendroflumethiazide—Anorexia—Bicalutamide—prostate cancer	0.00171	0.00369	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Mitoxantrone—prostate cancer	0.0017	0.00368	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Estradiol—prostate cancer	0.0017	0.00368	CcSEcCtD
Bendroflumethiazide—Vomiting—Estrone—prostate cancer	0.0017	0.00367	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Nilutamide—prostate cancer	0.0017	0.00366	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Flutamide—prostate cancer	0.00169	0.00365	CcSEcCtD
Bendroflumethiazide—Rash—Estrone—prostate cancer	0.00168	0.00364	CcSEcCtD
Bendroflumethiazide—Dermatitis—Estrone—prostate cancer	0.00168	0.00363	CcSEcCtD
Bendroflumethiazide—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.00167	0.00361	CcSEcCtD
Bendroflumethiazide—Nausea—Estramustine—prostate cancer	0.00166	0.00359	CcSEcCtD
Bendroflumethiazide—Dizziness—Nilutamide—prostate cancer	0.00164	0.00354	CcSEcCtD
Bendroflumethiazide—Dizziness—Flutamide—prostate cancer	0.00163	0.00353	CcSEcCtD
Bendroflumethiazide—Asthenia—Degarelix—prostate cancer	0.00159	0.00343	CcSEcCtD
Bendroflumethiazide—Nausea—Estrone—prostate cancer	0.00159	0.00343	CcSEcCtD
Bendroflumethiazide—Vomiting—Nilutamide—prostate cancer	0.00158	0.00341	CcSEcCtD
Bendroflumethiazide—Vomiting—Flutamide—prostate cancer	0.00157	0.00339	CcSEcCtD
Bendroflumethiazide—Rash—Nilutamide—prostate cancer	0.00156	0.00338	CcSEcCtD
Bendroflumethiazide—Dermatitis—Nilutamide—prostate cancer	0.00156	0.00337	CcSEcCtD
Bendroflumethiazide—Urine output increased—Capecitabine—prostate cancer	0.00156	0.00337	CcSEcCtD
Bendroflumethiazide—Rash—Flutamide—prostate cancer	0.00156	0.00336	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Bicalutamide—prostate cancer	0.00156	0.00336	CcSEcCtD
Bendroflumethiazide—Dermatitis—Flutamide—prostate cancer	0.00155	0.00336	CcSEcCtD
Bendroflumethiazide—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.00154	0.00333	CcSEcCtD
Bendroflumethiazide—Constipation—Bicalutamide—prostate cancer	0.00153	0.00331	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Degarelix—prostate cancer	0.00152	0.00327	CcSEcCtD
Bendroflumethiazide—Asthenia—Cabazitaxel—prostate cancer	0.0015	0.00323	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Mitoxantrone—prostate cancer	0.00149	0.00322	CcSEcCtD
Bendroflumethiazide—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.00148	0.0032	CcSEcCtD
Bendroflumethiazide—Nausea—Nilutamide—prostate cancer	0.00147	0.00318	CcSEcCtD
Bendroflumethiazide—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00147	0.00317	CcSEcCtD
Bendroflumethiazide—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.00147	0.00317	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Goserelin—prostate cancer	0.00147	0.00317	CcSEcCtD
Bendroflumethiazide—Nausea—Flutamide—prostate cancer	0.00147	0.00317	CcSEcCtD
Bendroflumethiazide—Dizziness—Degarelix—prostate cancer	0.00146	0.00316	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Conjugated Estrogens—prostate cancer	0.00145	0.00314	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Capecitabine—prostate cancer	0.00144	0.00311	CcSEcCtD
Bendroflumethiazide—Blood disorder—Epirubicin—prostate cancer	0.00144	0.00311	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Cabazitaxel—prostate cancer	0.00143	0.00308	CcSEcCtD
Bendroflumethiazide—Polyuria—Capecitabine—prostate cancer	0.00143	0.00308	CcSEcCtD
Bendroflumethiazide—Vomiting—Degarelix—prostate cancer	0.00141	0.00304	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Etoposide—prostate cancer	0.0014	0.00303	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Capecitabine—prostate cancer	0.0014	0.00302	CcSEcCtD
Bendroflumethiazide—Rash—Degarelix—prostate cancer	0.0014	0.00302	CcSEcCtD
Bendroflumethiazide—Dermatitis—Degarelix—prostate cancer	0.00139	0.00301	CcSEcCtD
Bendroflumethiazide—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00138	0.00299	CcSEcCtD
Bendroflumethiazide—Dizziness—Cabazitaxel—prostate cancer	0.00138	0.00298	CcSEcCtD
Bendroflumethiazide—Blood disorder—Doxorubicin—prostate cancer	0.00133	0.00288	CcSEcCtD
Bendroflumethiazide—Vomiting—Cabazitaxel—prostate cancer	0.00133	0.00287	CcSEcCtD
Bendroflumethiazide—Thirst—Capecitabine—prostate cancer	0.00132	0.00284	CcSEcCtD
Bendroflumethiazide—Nausea—Degarelix—prostate cancer	0.00132	0.00284	CcSEcCtD
Bendroflumethiazide—Purpura—Capecitabine—prostate cancer	0.0013	0.00281	CcSEcCtD
Bendroflumethiazide—Constipation—Ethinyl Estradiol—prostate cancer	0.00129	0.0028	CcSEcCtD
Bendroflumethiazide—Asthenia—Bicalutamide—prostate cancer	0.00128	0.00277	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Prednisone—prostate cancer	0.00128	0.00277	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Prednisone—prostate cancer	0.00125	0.00269	CcSEcCtD
Bendroflumethiazide—Nausea—Cabazitaxel—prostate cancer	0.00124	0.00268	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Bicalutamide—prostate cancer	0.00122	0.00265	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Goserelin—prostate cancer	0.00122	0.00263	CcSEcCtD
Bendroflumethiazide—Anorexia—Goserelin—prostate cancer	0.00119	0.00256	CcSEcCtD
Bendroflumethiazide—Dizziness—Bicalutamide—prostate cancer	0.00118	0.00256	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Docetaxel—prostate cancer	0.00118	0.00255	CcSEcCtD
Bendroflumethiazide—Anorexia—Conjugated Estrogens—prostate cancer	0.00118	0.00254	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Docetaxel—prostate cancer	0.00116	0.00252	CcSEcCtD
Bendroflumethiazide—Hypotension—Goserelin—prostate cancer	0.00116	0.00251	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Estradiol—prostate cancer	0.00116	0.00251	CcSEcCtD
Bendroflumethiazide—Purpura—Prednisone—prostate cancer	0.00116	0.0025	CcSEcCtD
Bendroflumethiazide—Hypotension—Conjugated Estrogens—prostate cancer	0.00115	0.00249	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Capecitabine—prostate cancer	0.00114	0.00247	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Capecitabine—prostate cancer	0.00114	0.00246	CcSEcCtD
Bendroflumethiazide—Vomiting—Bicalutamide—prostate cancer	0.00114	0.00246	CcSEcCtD
Bendroflumethiazide—Rash—Bicalutamide—prostate cancer	0.00113	0.00244	CcSEcCtD
Bendroflumethiazide—Dermatitis—Bicalutamide—prostate cancer	0.00113	0.00244	CcSEcCtD
Bendroflumethiazide—Asthenia—Ethinyl Estradiol—prostate cancer	0.00109	0.00235	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Goserelin—prostate cancer	0.00108	0.00234	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Conjugated Estrogens—prostate cancer	0.00107	0.00232	CcSEcCtD
Bendroflumethiazide—Constipation—Goserelin—prostate cancer	0.00106	0.0023	CcSEcCtD
Bendroflumethiazide—Nausea—Bicalutamide—prostate cancer	0.00106	0.0023	CcSEcCtD
Bendroflumethiazide—Constipation—Conjugated Estrogens—prostate cancer	0.00105	0.00228	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00103	0.00224	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Prednisone—prostate cancer	0.00102	0.00219	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Epirubicin—prostate cancer	0.001	0.00217	CcSEcCtD
Bendroflumethiazide—Dizziness—Ethinyl Estradiol—prostate cancer	0.001	0.00216	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Epirubicin—prostate cancer	0.000975	0.00211	CcSEcCtD
Bendroflumethiazide—Vomiting—Ethinyl Estradiol—prostate cancer	0.000962	0.00208	CcSEcCtD
Bendroflumethiazide—Rash—Ethinyl Estradiol—prostate cancer	0.000954	0.00206	CcSEcCtD
Bendroflumethiazide—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000953	0.00206	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Prednisone—prostate cancer	0.000945	0.00204	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Doxorubicin—prostate cancer	0.000928	0.00201	CcSEcCtD
Bendroflumethiazide—Purpura—Epirubicin—prostate cancer	0.000905	0.00196	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Doxorubicin—prostate cancer	0.000902	0.00195	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Etoposide—prostate cancer	0.000901	0.00195	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Mitoxantrone—prostate cancer	0.0009	0.00195	CcSEcCtD
Bendroflumethiazide—Nausea—Ethinyl Estradiol—prostate cancer	0.000898	0.00194	CcSEcCtD
Bendroflumethiazide—Asthenia—Goserelin—prostate cancer	0.000893	0.00193	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Prednisone—prostate cancer	0.000888	0.00192	CcSEcCtD
Bendroflumethiazide—Asthenia—Conjugated Estrogens—prostate cancer	0.000885	0.00191	CcSEcCtD
Bendroflumethiazide—Anorexia—Mitoxantrone—prostate cancer	0.000876	0.00189	CcSEcCtD
Bendroflumethiazide—Hypotension—Mitoxantrone—prostate cancer	0.000859	0.00186	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Estradiol—prostate cancer	0.000858	0.00185	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Goserelin—prostate cancer	0.000852	0.00184	CcSEcCtD
Bendroflumethiazide—Constipation—Estradiol—prostate cancer	0.000844	0.00182	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000844	0.00182	CcSEcCtD
Bendroflumethiazide—Purpura—Doxorubicin—prostate cancer	0.000837	0.00181	CcSEcCtD
Bendroflumethiazide—Dizziness—Goserelin—prostate cancer	0.000823	0.00178	CcSEcCtD
Bendroflumethiazide—Dizziness—Conjugated Estrogens—prostate cancer	0.000815	0.00176	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Mitoxantrone—prostate cancer	0.000799	0.00173	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Epirubicin—prostate cancer	0.000797	0.00172	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Epirubicin—prostate cancer	0.000794	0.00172	CcSEcCtD
Bendroflumethiazide—Vomiting—Goserelin—prostate cancer	0.000791	0.00171	CcSEcCtD
Bendroflumethiazide—Constipation—Mitoxantrone—prostate cancer	0.000786	0.0017	CcSEcCtD
Bendroflumethiazide—Rash—Goserelin—prostate cancer	0.000785	0.0017	CcSEcCtD
Bendroflumethiazide—Dermatitis—Goserelin—prostate cancer	0.000784	0.00169	CcSEcCtD
Bendroflumethiazide—Vomiting—Conjugated Estrogens—prostate cancer	0.000784	0.00169	CcSEcCtD
Bendroflumethiazide—Rash—Conjugated Estrogens—prostate cancer	0.000777	0.00168	CcSEcCtD
Bendroflumethiazide—Dermatitis—Conjugated Estrogens—prostate cancer	0.000777	0.00168	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Etoposide—prostate cancer	0.000749	0.00162	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Docetaxel—prostate cancer	0.000749	0.00162	CcSEcCtD
Bendroflumethiazide—Nausea—Goserelin—prostate cancer	0.000739	0.0016	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Epirubicin—prostate cancer	0.000739	0.0016	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Doxorubicin—prostate cancer	0.000737	0.00159	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Doxorubicin—prostate cancer	0.000735	0.00159	CcSEcCtD
Bendroflumethiazide—Nausea—Conjugated Estrogens—prostate cancer	0.000732	0.00158	CcSEcCtD
Bendroflumethiazide—Anorexia—Etoposide—prostate cancer	0.000729	0.00158	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Capecitabine—prostate cancer	0.000725	0.00157	CcSEcCtD
Bendroflumethiazide—Hypotension—Etoposide—prostate cancer	0.000715	0.00154	CcSEcCtD
Bendroflumethiazide—Asthenia—Estradiol—prostate cancer	0.000708	0.00153	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Doxorubicin—prostate cancer	0.000684	0.00148	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Estradiol—prostate cancer	0.000675	0.00146	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Etoposide—prostate cancer	0.000665	0.00144	CcSEcCtD
Bendroflumethiazide—Asthenia—Mitoxantrone—prostate cancer	0.00066	0.00143	CcSEcCtD
Bendroflumethiazide—Constipation—Etoposide—prostate cancer	0.000654	0.00141	CcSEcCtD
Bendroflumethiazide—Dizziness—Estradiol—prostate cancer	0.000653	0.00141	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Mitoxantrone—prostate cancer	0.000629	0.00136	CcSEcCtD
Bendroflumethiazide—Vomiting—Estradiol—prostate cancer	0.000627	0.00136	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Docetaxel—prostate cancer	0.000622	0.00134	CcSEcCtD
Bendroflumethiazide—Rash—Estradiol—prostate cancer	0.000622	0.00134	CcSEcCtD
Bendroflumethiazide—Dermatitis—Estradiol—prostate cancer	0.000622	0.00134	CcSEcCtD
Bendroflumethiazide—Anorexia—Docetaxel—prostate cancer	0.000606	0.00131	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Capecitabine—prostate cancer	0.000603	0.0013	CcSEcCtD
Bendroflumethiazide—Hypotension—Docetaxel—prostate cancer	0.000594	0.00128	CcSEcCtD
Bendroflumethiazide—Anorexia—Capecitabine—prostate cancer	0.000587	0.00127	CcSEcCtD
Bendroflumethiazide—Nausea—Estradiol—prostate cancer	0.000586	0.00127	CcSEcCtD
Bendroflumethiazide—Vomiting—Mitoxantrone—prostate cancer	0.000585	0.00126	CcSEcCtD
Bendroflumethiazide—Rash—Mitoxantrone—prostate cancer	0.00058	0.00125	CcSEcCtD
Bendroflumethiazide—Dermatitis—Mitoxantrone—prostate cancer	0.000579	0.00125	CcSEcCtD
Bendroflumethiazide—Hypotension—Capecitabine—prostate cancer	0.000575	0.00124	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Docetaxel—prostate cancer	0.000553	0.00119	CcSEcCtD
Bendroflumethiazide—Asthenia—Etoposide—prostate cancer	0.000549	0.00119	CcSEcCtD
Bendroflumethiazide—Nausea—Mitoxantrone—prostate cancer	0.000546	0.00118	CcSEcCtD
Bendroflumethiazide—Constipation—Docetaxel—prostate cancer	0.000544	0.00117	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Capecitabine—prostate cancer	0.000535	0.00116	CcSEcCtD
Bendroflumethiazide—Constipation—Capecitabine—prostate cancer	0.000526	0.00114	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Etoposide—prostate cancer	0.000523	0.00113	CcSEcCtD
Bendroflumethiazide—Anorexia—Prednisone—prostate cancer	0.000523	0.00113	CcSEcCtD
Bendroflumethiazide—Dizziness—Etoposide—prostate cancer	0.000506	0.00109	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Epirubicin—prostate cancer	0.000505	0.00109	CcSEcCtD
Bendroflumethiazide—Vomiting—Etoposide—prostate cancer	0.000486	0.00105	CcSEcCtD
Bendroflumethiazide—Rash—Etoposide—prostate cancer	0.000482	0.00104	CcSEcCtD
Bendroflumethiazide—Dermatitis—Etoposide—prostate cancer	0.000482	0.00104	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Prednisone—prostate cancer	0.000477	0.00103	CcSEcCtD
Bendroflumethiazide—Constipation—Prednisone—prostate cancer	0.000469	0.00101	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Doxorubicin—prostate cancer	0.000467	0.00101	CcSEcCtD
Bendroflumethiazide—Asthenia—Docetaxel—prostate cancer	0.000456	0.000985	CcSEcCtD
Bendroflumethiazide—Nausea—Etoposide—prostate cancer	0.000454	0.000982	CcSEcCtD
Bendroflumethiazide—Asthenia—Capecitabine—prostate cancer	0.000442	0.000954	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Docetaxel—prostate cancer	0.000435	0.00094	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Capecitabine—prostate cancer	0.000421	0.00091	CcSEcCtD
Bendroflumethiazide—Dizziness—Docetaxel—prostate cancer	0.00042	0.000908	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Epirubicin—prostate cancer	0.00042	0.000907	CcSEcCtD
Bendroflumethiazide—Anorexia—Epirubicin—prostate cancer	0.000409	0.000883	CcSEcCtD
Bendroflumethiazide—Dizziness—Capecitabine—prostate cancer	0.000407	0.000879	CcSEcCtD
Bendroflumethiazide—Vomiting—Docetaxel—prostate cancer	0.000404	0.000873	CcSEcCtD
Bendroflumethiazide—Rash—Docetaxel—prostate cancer	0.000401	0.000866	CcSEcCtD
Bendroflumethiazide—Hypotension—Epirubicin—prostate cancer	0.000401	0.000866	CcSEcCtD
Bendroflumethiazide—Dermatitis—Docetaxel—prostate cancer	0.0004	0.000865	CcSEcCtD
Bendroflumethiazide—Asthenia—Prednisone—prostate cancer	0.000393	0.00085	CcSEcCtD
Bendroflumethiazide—Vomiting—Capecitabine—prostate cancer	0.000391	0.000846	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Doxorubicin—prostate cancer	0.000388	0.000839	CcSEcCtD
Bendroflumethiazide—Rash—Capecitabine—prostate cancer	0.000388	0.000838	CcSEcCtD
Bendroflumethiazide—Dermatitis—Capecitabine—prostate cancer	0.000388	0.000838	CcSEcCtD
Bendroflumethiazide—Anorexia—Doxorubicin—prostate cancer	0.000378	0.000817	CcSEcCtD
Bendroflumethiazide—Nausea—Docetaxel—prostate cancer	0.000378	0.000816	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Prednisone—prostate cancer	0.000375	0.00081	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Epirubicin—prostate cancer	0.000373	0.000805	CcSEcCtD
Bendroflumethiazide—Hypotension—Doxorubicin—prostate cancer	0.000371	0.000801	CcSEcCtD
Bendroflumethiazide—Constipation—Epirubicin—prostate cancer	0.000367	0.000792	CcSEcCtD
Bendroflumethiazide—Nausea—Capecitabine—prostate cancer	0.000366	0.00079	CcSEcCtD
Bendroflumethiazide—Dizziness—Prednisone—prostate cancer	0.000362	0.000783	CcSEcCtD
Bendroflumethiazide—Vomiting—Prednisone—prostate cancer	0.000349	0.000753	CcSEcCtD
Bendroflumethiazide—Rash—Prednisone—prostate cancer	0.000346	0.000747	CcSEcCtD
Bendroflumethiazide—Dermatitis—Prednisone—prostate cancer	0.000345	0.000746	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Doxorubicin—prostate cancer	0.000345	0.000745	CcSEcCtD
Bendroflumethiazide—Constipation—Doxorubicin—prostate cancer	0.000339	0.000733	CcSEcCtD
Bendroflumethiazide—Nausea—Prednisone—prostate cancer	0.000326	0.000704	CcSEcCtD
Bendroflumethiazide—Asthenia—Epirubicin—prostate cancer	0.000308	0.000665	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Epirubicin—prostate cancer	0.000293	0.000634	CcSEcCtD
Bendroflumethiazide—Asthenia—Doxorubicin—prostate cancer	0.000285	0.000615	CcSEcCtD
Bendroflumethiazide—Dizziness—Epirubicin—prostate cancer	0.000284	0.000613	CcSEcCtD
Bendroflumethiazide—Vomiting—Epirubicin—prostate cancer	0.000273	0.000589	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Doxorubicin—prostate cancer	0.000271	0.000587	CcSEcCtD
Bendroflumethiazide—Rash—Epirubicin—prostate cancer	0.00027	0.000584	CcSEcCtD
Bendroflumethiazide—Dermatitis—Epirubicin—prostate cancer	0.00027	0.000584	CcSEcCtD
Bendroflumethiazide—Dizziness—Doxorubicin—prostate cancer	0.000262	0.000567	CcSEcCtD
Bendroflumethiazide—Nausea—Epirubicin—prostate cancer	0.000255	0.00055	CcSEcCtD
Bendroflumethiazide—Vomiting—Doxorubicin—prostate cancer	0.000252	0.000545	CcSEcCtD
Bendroflumethiazide—Rash—Doxorubicin—prostate cancer	0.00025	0.00054	CcSEcCtD
Bendroflumethiazide—Dermatitis—Doxorubicin—prostate cancer	0.00025	0.00054	CcSEcCtD
Bendroflumethiazide—Nausea—Doxorubicin—prostate cancer	0.000236	0.000509	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—PLAU—prostate cancer	0.000183	0.000489	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—HPGDS—prostate cancer	0.000181	0.000484	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP2C19—prostate cancer	0.00018	0.000481	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—CAV1—prostate cancer	0.000179	0.000478	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—TCN2—prostate cancer	0.000177	0.000473	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTA3—prostate cancer	0.000177	0.000473	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PDHA1—prostate cancer	0.000177	0.000473	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—UCP3—prostate cancer	0.000177	0.000473	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC22A3—prostate cancer	0.000176	0.000471	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HSD3B1—prostate cancer	0.000176	0.000471	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTA4—prostate cancer	0.000176	0.000471	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—TBXAS1—prostate cancer	0.000176	0.000471	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ACHE—prostate cancer	0.000176	0.000469	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTT1—prostate cancer	0.000176	0.000469	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP2A6—prostate cancer	0.000174	0.000464	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000173	0.000464	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTA2—prostate cancer	0.000172	0.000459	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ABCG5—prostate cancer	0.000169	0.000453	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SULT1A1—prostate cancer	0.000169	0.000453	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—TBXAS1—prostate cancer	0.000169	0.000451	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—AKR1C3—prostate cancer	0.000169	0.000451	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HSD3B1—prostate cancer	0.000169	0.000451	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTA4—prostate cancer	0.000169	0.000451	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC22A3—prostate cancer	0.000169	0.000451	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PRKACB—prostate cancer	0.000168	0.000449	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP17A1—prostate cancer	0.000166	0.000444	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTA1—prostate cancer	0.000166	0.000443	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTA2—prostate cancer	0.000164	0.00044	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTO1—prostate cancer	0.000164	0.000438	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HSD3B2—prostate cancer	0.000164	0.000438	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NAT2—prostate cancer	0.000164	0.000438	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CG—prostate cancer	0.000163	0.000435	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ABCG5—prostate cancer	0.000162	0.000434	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SULT1A1—prostate cancer	0.000162	0.000434	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—TBXAS1—prostate cancer	0.000162	0.000433	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTA4—prostate cancer	0.000162	0.000433	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—EGF—prostate cancer	0.000161	0.00043	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTA1—prostate cancer	0.000159	0.000424	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NCOA2—prostate cancer	0.000158	0.000423	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTA2—prostate cancer	0.000158	0.000422	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HSD3B2—prostate cancer	0.000157	0.00042	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTO1—prostate cancer	0.000157	0.00042	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PLCB2—prostate cancer	0.000157	0.00042	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP2C18—prostate cancer	0.000157	0.00042	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NAT2—prostate cancer	0.000157	0.00042	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—LRP2—prostate cancer	0.000157	0.00042	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SULT1A1—prostate cancer	0.000156	0.000417	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ABCG5—prostate cancer	0.000156	0.000417	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—P4HB—prostate cancer	0.000154	0.000412	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—TP53—prostate cancer	0.000154	0.000411	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTA1—prostate cancer	0.000152	0.000407	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—SLC5A5—prostate cancer	0.000151	0.000404	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—CREBBP—prostate cancer	0.000151	0.000403	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PLCB2—prostate cancer	0.00015	0.000402	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—LRP2—prostate cancer	0.00015	0.000402	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HSD3B2—prostate cancer	0.00015	0.000402	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP2C18—prostate cancer	0.00015	0.000402	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTO1—prostate cancer	0.00015	0.000402	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NAT2—prostate cancer	0.00015	0.000402	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SLC22A1—prostate cancer	0.00015	0.0004	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IGF1—prostate cancer	0.000149	0.000398	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—P4HB—prostate cancer	0.000148	0.000395	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP2E1—prostate cancer	0.000148	0.000395	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SULT2A1—prostate cancer	0.000146	0.00039	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NQO1—prostate cancer	0.000146	0.00039	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PLCB2—prostate cancer	0.000144	0.000386	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—LRP2—prostate cancer	0.000144	0.000386	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP2C18—prostate cancer	0.000144	0.000386	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—TH—prostate cancer	0.000144	0.000384	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC22A1—prostate cancer	0.000144	0.000384	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MED12—prostate cancer	0.000144	0.000384	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CD—prostate cancer	0.000143	0.000382	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GNG5—prostate cancer	0.000142	0.000381	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP3A4—prostate cancer	0.000142	0.00038	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—P4HB—prostate cancer	0.000141	0.000378	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—SERPINE1—prostate cancer	0.000141	0.000378	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—IL6—prostate cancer	0.000141	0.000377	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SULT2A1—prostate cancer	0.00014	0.000374	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP1B1—prostate cancer	0.00014	0.000374	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000138	0.000368	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC22A1—prostate cancer	0.000138	0.000368	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MED12—prostate cancer	0.000138	0.000368	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NCOA3—prostate cancer	0.000137	0.000367	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GNG5—prostate cancer	0.000137	0.000365	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GGT1—prostate cancer	0.000135	0.000362	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—NOS3—prostate cancer	0.000135	0.000361	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SULT2A1—prostate cancer	0.000134	0.000359	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NCOA1—prostate cancer	0.000133	0.000357	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MED12—prostate cancer	0.000132	0.000353	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NCOA3—prostate cancer	0.000131	0.000352	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP19A1—prostate cancer	0.000131	0.000352	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—JAK2—prostate cancer	0.000131	0.000351	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GNG5—prostate cancer	0.000131	0.00035	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HPGDS—prostate cancer	0.000131	0.00035	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP2C19—prostate cancer	0.00013	0.000348	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTT1—prostate cancer	0.000127	0.000339	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—RXRA—prostate cancer	0.000127	0.000339	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ACHE—prostate cancer	0.000127	0.000339	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NCOA3—prostate cancer	0.000126	0.000337	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HPGDS—prostate cancer	0.000125	0.000335	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP2A6—prostate cancer	0.000125	0.000335	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP2C19—prostate cancer	0.000125	0.000333	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CB—prostate cancer	0.000125	0.000333	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—COMT—prostate cancer	0.000122	0.000327	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—AKR1C3—prostate cancer	0.000122	0.000326	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ACHE—prostate cancer	0.000122	0.000325	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTT1—prostate cancer	0.000122	0.000325	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTP1—prostate cancer	0.000122	0.000325	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PRKACB—prostate cancer	0.000121	0.000325	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP2A6—prostate cancer	0.00012	0.000322	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HPGDS—prostate cancer	0.00012	0.000322	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP17A1—prostate cancer	0.00012	0.000321	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ITPR1—prostate cancer	0.00012	0.00032	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP2C19—prostate cancer	0.00012	0.00032	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—AKR1C3—prostate cancer	0.000117	0.000313	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ACHE—prostate cancer	0.000117	0.000312	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTT1—prostate cancer	0.000117	0.000312	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PRKACB—prostate cancer	0.000116	0.000311	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP2A6—prostate cancer	0.000115	0.000308	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP17A1—prostate cancer	0.000115	0.000308	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IL2—prostate cancer	0.000114	0.000306	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NCOA2—prostate cancer	0.000114	0.000306	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—TYMS—prostate cancer	0.000113	0.000302	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—AKR1C3—prostate cancer	0.000112	0.0003	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTM1—prostate cancer	0.000112	0.000299	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PRKACB—prostate cancer	0.000112	0.000298	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP17A1—prostate cancer	0.00011	0.000295	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NCOA2—prostate cancer	0.00011	0.000293	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—LPL—prostate cancer	0.00011	0.000293	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SLC5A5—prostate cancer	0.000109	0.000292	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP2E1—prostate cancer	0.000107	0.000285	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP1A1—prostate cancer	0.000106	0.000283	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NQO1—prostate cancer	0.000105	0.000282	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NCOA2—prostate cancer	0.000105	0.000281	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ERCC2—prostate cancer	0.000105	0.000281	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC5A5—prostate cancer	0.000105	0.00028	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—TH—prostate cancer	0.000104	0.000278	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP3A4—prostate cancer	0.000103	0.000275	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—EP300—prostate cancer	0.000103	0.000275	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP2E1—prostate cancer	0.000102	0.000273	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NQO1—prostate cancer	0.000101	0.00027	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP1B1—prostate cancer	0.000101	0.00027	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC5A5—prostate cancer	0.0001	0.000268	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—SRC—prostate cancer	9.99e-05	0.000267	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—TH—prostate cancer	9.97e-05	0.000266	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—MTHFR—prostate cancer	9.88e-05	0.000264	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP3A4—prostate cancer	9.86e-05	0.000264	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP2E1—prostate cancer	9.8e-05	0.000262	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GGT1—prostate cancer	9.79e-05	0.000262	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—VEGFA—prostate cancer	9.73e-05	0.00026	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP1B1—prostate cancer	9.69e-05	0.000259	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PPARA—prostate cancer	9.69e-05	0.000259	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NQO1—prostate cancer	9.69e-05	0.000259	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NCOA1—prostate cancer	9.65e-05	0.000258	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—TH—prostate cancer	9.55e-05	0.000255	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP19A1—prostate cancer	9.51e-05	0.000254	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP3A4—prostate cancer	9.45e-05	0.000253	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GGT1—prostate cancer	9.39e-05	0.000251	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP1B1—prostate cancer	9.29e-05	0.000249	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NCOA1—prostate cancer	9.25e-05	0.000247	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—RXRA—prostate cancer	9.18e-05	0.000245	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP19A1—prostate cancer	9.11e-05	0.000244	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CAV1—prostate cancer	9.11e-05	0.000244	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GGT1—prostate cancer	9e-05	0.000241	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—TGFB1—prostate cancer	8.93e-05	0.000239	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NCOA1—prostate cancer	8.87e-05	0.000237	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—COMT—prostate cancer	8.84e-05	0.000236	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—RXRA—prostate cancer	8.8e-05	0.000235	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTP1—prostate cancer	8.8e-05	0.000235	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP19A1—prostate cancer	8.74e-05	0.000234	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ITPR1—prostate cancer	8.66e-05	0.000231	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—COMT—prostate cancer	8.47e-05	0.000227	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTP1—prostate cancer	8.43e-05	0.000226	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—RXRA—prostate cancer	8.43e-05	0.000226	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CG—prostate cancer	8.3e-05	0.000222	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ITPR1—prostate cancer	8.3e-05	0.000222	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—KRAS—prostate cancer	8.27e-05	0.000221	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—TYMS—prostate cancer	8.18e-05	0.000219	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—COMT—prostate cancer	8.12e-05	0.000217	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTP1—prostate cancer	8.09e-05	0.000216	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTM1—prostate cancer	8.08e-05	0.000216	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ITPR1—prostate cancer	7.96e-05	0.000213	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—LPL—prostate cancer	7.93e-05	0.000212	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—INS—prostate cancer	7.86e-05	0.00021	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—TYMS—prostate cancer	7.84e-05	0.00021	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTM1—prostate cancer	7.75e-05	0.000207	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CREBBP—prostate cancer	7.7e-05	0.000206	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP1A1—prostate cancer	7.66e-05	0.000205	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—LPL—prostate cancer	7.61e-05	0.000203	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ERCC2—prostate cancer	7.6e-05	0.000203	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CA—prostate cancer	7.6e-05	0.000203	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—TYMS—prostate cancer	7.52e-05	0.000201	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTM1—prostate cancer	7.43e-05	0.000199	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—TP53—prostate cancer	7.35e-05	0.000197	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP1A1—prostate cancer	7.35e-05	0.000196	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CD—prostate cancer	7.3e-05	0.000195	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—LPL—prostate cancer	7.29e-05	0.000195	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ERCC2—prostate cancer	7.29e-05	0.000195	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MTHFR—prostate cancer	7.14e-05	0.000191	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP1A1—prostate cancer	7.04e-05	0.000188	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PPARA—prostate cancer	7.01e-05	0.000187	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ERCC2—prostate cancer	6.99e-05	0.000187	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NOS3—prostate cancer	6.89e-05	0.000184	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MTHFR—prostate cancer	6.85e-05	0.000183	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PPARA—prostate cancer	6.72e-05	0.00018	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CAV1—prostate cancer	6.59e-05	0.000176	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MTHFR—prostate cancer	6.57e-05	0.000176	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PPARA—prostate cancer	6.44e-05	0.000172	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CB—prostate cancer	6.36e-05	0.00017	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CAV1—prostate cancer	6.32e-05	0.000169	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PTGS2—prostate cancer	6.3e-05	0.000169	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—AKT1—prostate cancer	6.21e-05	0.000166	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CAV1—prostate cancer	6.06e-05	0.000162	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CG—prostate cancer	6e-05	0.000161	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CG—prostate cancer	5.75e-05	0.000154	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—INS—prostate cancer	5.68e-05	0.000152	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CREBBP—prostate cancer	5.57e-05	0.000149	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CG—prostate cancer	5.52e-05	0.000148	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PTEN—prostate cancer	5.5e-05	0.000147	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—INS—prostate cancer	5.45e-05	0.000146	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CREBBP—prostate cancer	5.34e-05	0.000143	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CD—prostate cancer	5.28e-05	0.000141	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—EP300—prostate cancer	5.24e-05	0.00014	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—INS—prostate cancer	5.22e-05	0.00014	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CREBBP—prostate cancer	5.12e-05	0.000137	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CD—prostate cancer	5.06e-05	0.000135	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NOS3—prostate cancer	4.98e-05	0.000133	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CD—prostate cancer	4.85e-05	0.00013	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NOS3—prostate cancer	4.78e-05	0.000128	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CB—prostate cancer	4.6e-05	0.000123	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NOS3—prostate cancer	4.58e-05	0.000122	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PTGS2—prostate cancer	4.56e-05	0.000122	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CB—prostate cancer	4.41e-05	0.000118	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PTGS2—prostate cancer	4.37e-05	0.000117	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CB—prostate cancer	4.23e-05	0.000113	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PTGS2—prostate cancer	4.19e-05	0.000112	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PTEN—prostate cancer	3.97e-05	0.000106	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CA—prostate cancer	3.88e-05	0.000104	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PTEN—prostate cancer	3.81e-05	0.000102	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—EP300—prostate cancer	3.79e-05	0.000101	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PTEN—prostate cancer	3.65e-05	9.77e-05	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—EP300—prostate cancer	3.63e-05	9.72e-05	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—EP300—prostate cancer	3.48e-05	9.32e-05	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—AKT1—prostate cancer	3.17e-05	8.47e-05	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CA—prostate cancer	2.8e-05	7.5e-05	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CA—prostate cancer	2.69e-05	7.19e-05	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CA—prostate cancer	2.58e-05	6.89e-05	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—AKT1—prostate cancer	2.29e-05	6.12e-05	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—AKT1—prostate cancer	2.2e-05	5.87e-05	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—AKT1—prostate cancer	2.11e-05	5.63e-05	CbGpPWpGaD
